The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Traber Peter G since 2012.
This trader's CIK number is 1284500.
At the time of last reporting, Traber Peter G was the Chief Medical Officer of Selecta Biosciences Inc. (stock ticker symbol SELB).
Also see all insider trading activities at Selecta Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | SELB | 0 | $0 | 705 | $747 | 0 | $0 |
| 2022 | SELB | 0 | $0 | 3,226 | $9,955 | 0 | $0 |
| 2021 | SELB | 40,000 | $170,160 | 7,719 | $28,157 | 0 | $0 |
| 2020 | SELB | 40,000 | $129,440 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | GALT | 0 | $0 | 170,000 | $1,160,990 | 170,000 | $147,900 |
| 2015 | GALT | 6,000 | $14,120 | 0 | $0 | 0 | $0 |
| 2014 | GALT | 5,000 | $22,252 | 0 | $0 | 0 | $0 |
| 2013 | GALT | 3,000 | $20,279 | 0 | $0 | 0 | $0 |
| 2012 | GALT | 10,000 | $20,637 | 0 | $0 | 0 | $0 |
1. Selecta Biosciences Inc (SELB)
2. Galectin Therapeutics Inc (GALT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-25 | SELB | Sale | 705 | 1.06 | 747 |
| 2022-01-05 | SELB | Sale | 3,226 | 3.09 | 9,955 |
| 2021-12-10 | SELB | Sale | 4,083 | 2.99 | 12,195 |
| 2021-10-13 | SELB | Sale | 3,636 | 4.39 | 15,962 |
| 2021-05-26 | SELB | Buy | 20,000 | 3.99 | 79,860 |
| 2021-03-18 | SELB | Buy | 10,000 | 4.50 | 45,000 |
| 2021-03-17 | SELB | Buy | 10,000 | 4.53 | 45,300 |
| 2020-12-14 | SELB | Buy | 40,000 | 3.24 | 129,440 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-13 | GALT | Sale | 100,000 | 7.51 | 751,000 |
| 2018-06-13 | GALT | Option Ex | 100,000 | .87 | 87,000 |
| 2018-06-08 | GALT | Option Ex | 70,000 | .87 | 60,900 |
| 2018-06-08 | GALT | Sale | 70,000 | 5.86 | 409,990 |
| 2015-08-12 | GALT | Buy | 2,000 | 2.00 | 4,000 |
| 2015-06-01 | GALT | Buy | 4,000 | 2.53 | 10,120 |
| 2014-08-14 | GALT | Buy | 4,000 | 4.46 | 17,836 |
| 2014-08-13 | GALT | Buy | 1,000 | 4.42 | 4,416 |
| 2013-12-09 | GALT | Buy | 500 | 8.90 | 4,450 |
| 2013-12-05 | GALT | Buy | 500 | 9.00 | 4,500 |
| 2013-11-19 | GALT | Buy | 1,000 | 5.53 | 5,530 |
| 2013-11-18 | GALT | Buy | 1,000 | 5.80 | 5,799 |
| 2012-10-12 | GALT | Buy | 2,500 | 2.12 | 5,287 |
| 2012-10-09 | GALT | Buy | 2,500 | 2.00 | 5,000 |
| 2012-10-08 | GALT | Buy | 5,000 | 2.07 | 10,350 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Traber Peter G (Chief Medical Officer of Selecta Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.